Jung Jin Shin

ORCID: 0000-0002-0808-7206
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatology and Skin Diseases
  • Urticaria and Related Conditions
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Cancer and Skin Lesions
  • Contact Dermatitis and Allergies
  • Genetic and rare skin diseases.
  • Drug-Induced Adverse Reactions
  • Nail Diseases and Treatments
  • Pharmacological Effects of Natural Compounds
  • Medicinal Plants and Neuroprotection
  • Cancer Treatment and Pharmacology
  • Connective Tissue Growth Factor Research
  • Nonmelanoma Skin Cancer Studies
  • Chemotherapy-related skin toxicity
  • Facial Rejuvenation and Surgery Techniques
  • Ginseng Biological Effects and Applications
  • Advanced Antenna and Metasurface Technologies
  • Animal Genetics and Reproduction
  • Oral Health Pathology and Treatment
  • Infectious Diseases and Mycology
  • Dermatological and COVID-19 studies
  • Advanced Optical Imaging Technologies
  • Neurological Disorders and Treatments
  • Reconstructive Facial Surgery Techniques

Korea University
2014-2024

Ansan University
2023-2024

Korea Occupational Safety and Health Agency
2020

Background: Conventional procedures including botulinum toxin and filler injections have their limitations in improving deep wrinkles decreasing tissue laxity, possess the propensity for vascular accidents. Absorbable thread is a recently commercialized field, but there little evidence on comparative superiority. Objectives: We observed effects of polydiaxanone (PDO) threads with different number strands relation to collagen production histopathology rat model. Materials methods: Dorsal skin...

10.1080/14764172.2018.1493511 article EN Journal of Cosmetic and Laser Therapy 2018-07-06

Shin, Jung Jin MD; Park, Ji Hyun Lee, Min Ryu, Hwa MD, PhD Author Information

10.1097/dss.0000000000000807 article EN Dermatologic Surgery 2016-07-04

Dupilumab is a biologic medication that used for the treatment of moderate-to-severe atopic dermatitis (AD). Long-term data on dupilumab drug survival in Asia patients with AD are limited. A single-center, retrospective study was performed to assess between March 2019 and 2023. Drug associated characteristics were analyzed using Kaplan–Meier curves multivariate Cox regression analysis, respectively. total 124 (Mean age [standard deviation], 26.0 [8.6] years) 4 years-overall rate 87.9%,...

10.1038/s41598-024-62943-x article EN cc-by-nc-nd Scientific Reports 2024-07-23

Dear Editor: Skin manifestations in systemic lupus erythematosus (SLE) are very heterogeneous. Recently, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)-like (LE) has been reported. Clinically, this condition presents with photodistributed exanthema and minimal mucositis. The onset of the rash is insidious a prolonged clinical course1. A 16-year-old Korean woman presented 4-week history gradually progressive development painful, annular, erythematous, flattened,...

10.5021/ad.2016.28.1.117 article EN Annals of Dermatology 2016-01-01

<title>Abstract</title> Long-term data on dupilumab drug survival in Asia patients with atopic dermatitis (AD) are limited. A single-center, retrospective study was performed to assess between March 2019 and 2023. Drug associated characteristics were analyzed using Kaplan–Meier curves multivariate Cox regression analysis, respectively. total of 124 AD (Mean age [standard deviation], 26.0 [8.6] years) a 4 years-overall rate 87.9%, included this study. During the same period, 479 cyclosporine...

10.21203/rs.3.rs-3273651/v1 preprint EN cc-by Research Square (Research Square) 2023-08-25

Atopic dermatitis (AD) is a common skin disease which, depending on its severity, can have significant impact the quality of life affected individuals. In cases severe AD, systemic immunomodulatory agents be considered for treatment. However, available treatment options moderate AD are limited. According to previous reports, however, 308-nm excimer light potential localized, AD.This study aimed assess clinical efficacy and safety in Korean adults with included patients aged over 19 years,...

10.5021/ad.22.223 article EN Annals of Dermatology 2023-01-01
Coming Soon ...